Strategic partnerships Interrad Medical has a history of forming strategic distribution partnerships to expand reach, including recent collaborations with Eloquest Healthcare in the US and Vygon Group in the UK. Target potential distributors and hospital networks in regions with high catheter use to accelerate adoption of SecurAcath.

Cost saving value The SecurAcath device claims lower total cost of patient care through reduced infections, dislodgement, migration, and line complications. Use this to position value propositions to procurement and clinical teams emphasizing long term savings and reduced readmissions.

Clinical advantages The device eliminates adhesives and sutures, reduces infection risk, and supports longer catheter patency with confident dressing changes. Focus conversations on patient safety, clinical workflow efficiency, and reduced needle-stick risk to end users and infection control teams.

Expansion potential With revenue in a lower mid-range and a small company footprint, there is room to scale via channel partners and regional hospital networks. Prospects include large healthcare systems and medical distributors that serve acute care and specialty clinics.

Tech and credibility A composed tech stack and a focused niche product can be leveraged in outreach to hospitals prioritizing innovation and patient outcomes. Highlight evidence-based benefits, existing partnerships, and a clear path to training and implementation support.